Atrium Medical Recalls Ocean Blood Recovery Drains Due to Sterility Issues
Atrium Medical is recalling Ocean Blood Recovery Drains because the outer packaging is not sterile. The recall affects units worldwide with expiration dates prior to October 2019.
The agency’s classification
FDA (Devices): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, but the source text does not report any hospitalizations, injuries, or illnesses. The hazard is a packaging sterility issue, which fits the criteria for a moderate severity recall involving low-risk contamination or labeling/packaging errors without reported harm.
Plain-English summary
Atrium Medical Corporation is recalling specific models of Ocean Blood Recovery Drains, including catalog numbers 2050-000, 2050-300, 2052-000, and 2052-300. These medical devices are used to evacuate air and fluid from the chest cavity or mediastinum, help re-establish lung expansion, and facilitate the collection and reinfusion of autologous blood. The recall is being conducted because the outer packaging of these devices is not sterile.
The recall covers approximately 964,463 cases in the United States and 521,975 cases outside the US. The affected products were distributed worldwide, including in the US and numerous international markets such as Australia, Canada, China, France, Germany, and the United Kingdom. The recall applies to all lot numbers with an expiration date prior to October 2019.
Healthcare facilities and consumers should stop using the affected Ocean Blood Recovery Drains immediately. Atrium Medical is the recalling firm responsible for managing this Class II recall. Users should contact the manufacturer for further instructions on how to return or dispose of the affected units.
The recalled product
- Product
- Atrium Medical Ocean Blood Recovery Drains as follows: 2050-000 Ocean Blood Recovery drain with in-line connector and suction control stopcock 2050-300 Ocean Blood Recovery drain with suction control stopcock, no in-line connector 2052-000 Ocean Double Blood Recovery drain…
- Manufacturer
- Atrium Medical Corporation
- Category
- Medical Device — Surgical Drains
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All Lot Numbers With Expiration Date Prior To October 2019
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 10 recalled by Atrium Medical Corporation under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 10 products in this recall →Related recalls
Same manufacturer · Atrium Medical Corporation
See all →- HighAtrium Medical Recalls Getinge PVC Thoracic Catheters Due to Endotoxin Testing
FDA (Devices) · 2026-09-16
- HighAtrium Medical Recalls Getinge PVC Thoracic Catheters Due to Endotoxin Testing
FDA (Devices) · 2026-09-16
- HighAtrium Medical Recalls Getinge PVC Thoracic Catheters Due to Endotoxin Testing
FDA (Devices) · 2026-09-16
- ModerateiCast Covered Stent Recalled for Unique Device Identifier Labeling Error
FDA (Devices) · 2024-10-16
- HighVascular graft component separation reported in Advanta VXT devices
FDA (Devices) · 2024-06-12
Same hazard · sterility
See all →- HighFDA recalls injectable compounded mixture in single-use syringes
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- HighAtrium Ocean Water Seal Chest Drain ATS Blood Recovery System Recall
FDA (Devices) · 2014-01-22
- HighAtrium Ocean Water Seal Chest Drain ATS Blood Recovery System Recalled
FDA (Devices) · 2014-01-22
- HighAtrium Ocean Water Seal Chest Drain tubing may leak or disconnect
FDA (Devices) · 2014-01-22
- SevereAtrium Ocean Water Seal Chest Drain ATS Recall for Tubing Leaks
FDA (Devices) · 2014-01-22
- HighAtrium Medical Recalls Ocean Water Seal Chest Drains Due to Missing O-Ring
FDA (Devices) · 2015-07-08
- SevereAtrium Medical Recalls Chest Drain Tubing Due to Leak or Disconnect Risk
FDA (Devices) · 2014-01-22